pharmaceutical applications of epr v. paramagnetic ... · with the emxnano impurity concentrations...

2
All drugs contain impurities that can arise from the drug substances (APIs) or inert materials (excipients). They are also introduced into the drug product during the formulation processes, packaging, and storage. Impurities have many unwanted effects, such as: Decreasing the therapeutic effect Lowering the product shelf-life Inducing toxicity Identification, quantification, and control of impurities in API and the drug product are critical in drug development. Organic impurities are often free radicals from by-products, intermediates, or degradation products. Inorganic impurities include transition metals, reagents, and ligands. Electron Paramagnetic Resonance (EPR) spectroscopy is the only technique for the direct and non-invasive detection, identification and quantification of paramagnetic impurities (organic free radicals and transition metals). EPR is able to detect traces of impurities down to parts per billion levels. Challenge Identifying and monitoring impurities during drug develop- ment, manufacturing process as well as storage is critical to fulfill the regulatory requirements. Solution The Bruker EMXnano benchtop EPR spectrometer package Detects and identifying traces of transition metals Monitors drug degradation processes that produce and involve free radicals Observes the production of free radicals catalyzed by transition metals or other impurities Pharmaceutical Applications of EPR V. Paramagnetic Impurity Profiling Transition metal concentration Level of impurity EMXnano key features: No prior EPR experience needed Video how-to-guide and startup kit Accurate results Superior sensitivity Ease of use Full workflow for measuring, analyzing and quantifying free radicals Compact foot print Low cost of ownership Metal concentration correlates with the EPR signal

Upload: others

Post on 04-Jul-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Pharmaceutical Applications of EPR V. Paramagnetic ... · With the EMXnano impurity concentrations can be determined. Increasing amounts of metals accelerate the degradation of APIs

All drugs contain impurities that can arise from the drug substances (APIs) or inert materials (excipients). They are also introduced into the drug product during the formulation processes, packaging, and storage. Impurities have many unwanted effects, such as:

� Decreasing the therapeutic effect � Lowering the product shelf-life � Inducing toxicity

Identification, quantification, and control of impurities in API and the drug product are critical in drug development. Organic impurities are often free radicals from by-products, intermediates, or degradation products. Inorganic impurities include transition metals, reagents, and ligands.

Electron Paramagnetic Resonance (EPR) spectroscopy is the only technique for the direct and non-invasive detection, identification and quantification of paramagnetic impurities (organic free radicals and transition metals). EPR is able to detect traces of impurities down to parts per billion levels.

Challenge

Identifying and monitoring impurities during drug develop-ment, manufacturing process as well as storage is critical to fulfill the regulatory requirements.

Solution

The Bruker EMXnano benchtop EPR spectrometer package � Detects and identifying traces of transition metals � Monitors drug degradation processes that produce and involve free radicals

� Observes the production of free radicals catalyzed by transition metals or other impurities

Pharmaceutical Applications of EPR V. Paramagnetic Impurity Profiling

Tran

siti

on

met

al

con

cen

trat

ion

Level of im

pu

rity

EMXnano key features:

� No prior EPR experience needed � Video how-to-guide and startup kit � Accurate results � Superior sensitivity � Ease of use � Full workflow for measuring, analyzing and quantifying free radicals

� Compact foot print � Low cost of ownership

Metal concentration correlates with the EPR signal

Page 2: Pharmaceutical Applications of EPR V. Paramagnetic ... · With the EMXnano impurity concentrations can be determined. Increasing amounts of metals accelerate the degradation of APIs

Bruker [email protected] www.bruker.com/EMXnano

© B

ruke

r B

ioS

pin

09/1

7 T1

6558

2

I. Detecting and evaluatingdegradation • Photo (UV)

• Thermal

• Chemical

II. Optimizingstability & shelf-life • Drug stability

• Antioxidant

effectiveness

III. Reactionmonitoring • Yield optimization

• Green chemistry

IV. Sterilization Processes • Irradiation

• Thermal

V. ParamagneticImpurity Profiling • Trace elements

• Toxic by-products

Free Radicals

EPR SolutionsEMXnano Package

Drug Producttablet/emulsion

formulation

ExcipientsAPIs

Trace Analysis: Impurity Identification & Control

�� Manganese (Mn2+) and iron (Fe3+) are present at trace levels in the excipi-ent bentonite, commonly used as a filler in tablets.�� With the EMXnano impurity concentrations can be determined.�� Increasing amounts of metals accelerate the degradation of APIs and

excipients.

Summary

Detection, characterization, as well as monitoring of impurities and their impact on drug stability is essential and mandatory. The EMXnano package is your solution to the challenges of reac-tive impurities in pharmaceutical APIs, excipients, and formulations. With EPR one gains insight into the stability ‘soft spots’ of the drug which is important for developing a robust product.

References

1. Lam X.E. et al.(Genentech Inc.), Site-specific trypto-phan oxidation induced by autocatalytic reaction of polysorbate 20 in protein formulation, Pharm. Res. (2011) 28 2543

2. Wu Y. et al. (Bristol-Myers Squibb Co.), Understan-ding drug-excipient compatibility: Oxidation of compound A in a solid dosage form,  Pharm. Dev. Technol. (2009) 14 556

3. Williams H. (AstraZeneca), Claybourn M., The power of electron paramagnetic resonance spectroscopy in pharmaceutical analysis , Spectroscopy Europe (2006) 18(1)

�� Polysorbate 20 used in drug formulation as a stabilizer undergoes autoxidation.�� Autoxidation is catalyzed by transition metals

and results in side-chain cleavage and free radical formation.�� The EMXnano can detect, identify and quan-

tify the free radical impurities.

Bentonite

Iron (Fe3+) signal Manganese (Mn2+) signal

R

O+ Fe3+

Polysorbate 20

R

OC-centered alkyl radicalO2

ROO

OO-centered peroxyl radical

R

O

ROOH

O

ROO

ORO

OO-centered alkoxyl radical

+H

+ OH

Organic hydroperoxide

R

ROO

RO